Last reviewed · How we verify

NCT05112679: OPORP

Limb Health and Socket Pressure in Response to Powered Ankle Protheses

Completed NA Results posted Last updated 25 November 2025
What this trial tests

NA trial testing PROPRIO FOOT® by Ossur & Empower ankle by Ottobock in Pressure Ulcer, Ankle in 6 participants. Completed in 19 July 2023.

Timeline
15 November 2021
Primary endpoint
19 July 2023
19 July 2023

Quick facts

Lead sponsorIndiana University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment6
Start date15 November 2021
Primary completion19 July 2023
Estimated completion19 July 2023
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Indiana University

Who can join

18 and older, any sex, with Pressure Ulcer, Ankle or Prosthesis User. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Powered Transtibial Prosthesis on Socket Pressure Primary · 4 weeks

effects of a powered transtibial prosthesis on the socket pressure for level-ground walking to a microprocessor-controlled prosthesis and a passive prosthesis

GroupValue95% CI
Proprio Foot0.58± 0.01
Empower Ankle0.25± 0.03
Change in Skin Perfusion Secondary · 4 weeks

Changes measured with laser speckle imaging. The perfusion data is expressed as perfusion units (PU) which is a dimensionless ratio calculated by dividing the standard deviation of the intensity in a given area by the mean intensity within that area, essentially representing the degree of variation in the speckle pattern. Higher number indicates greater perfusion which is better outcome.

GroupValue95% CI
Proprio Foot1.1± 0.75
Empower Ankle0.8± 0.7
Transepidermal Water Loss (TEWL) Secondary · 4 weeks

Water loss change is measured via the TEWL device- the lower score mean a better outcome for TEWL.

GroupValue95% CI
Proprio Foot2.0± 0.61
Empower Ankle0.8± 0.21

Sponsor's own description

this project seeks to understand and quantify the effects of powered transtibial prostheses on socket loading and direct measures of residual limb health so as to inform the optimization of prosthesis fit.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Measurement of Transepidermal Water Loss.
    Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148

Verify or expand the search:

Other Indiana University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05112679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing